|
gptkbp:instance_of
|
gptkb:virus
|
|
gptkbp:affects
|
gptkb:civet_cats
gptkb:Person
bats
camels
post-acute sequelae of SARS-Co V-2 infection (PASC)
|
|
gptkbp:associated_with
|
gptkb:COVID-19
|
|
gptkbp:caused_by
|
respiratory illness
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:family
|
gptkb:virus
|
|
gptkbp:genetic_diversity
|
moderate
|
|
gptkbp:genus
|
gptkb:Betacoronavirus
|
|
gptkbp:healthcare
|
contact tracing
mask mandates
quarantine
social distancing
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
beta coronavirus
|
|
gptkbp:impact
|
mental health
education systems
healthcare systems
economies
|
|
gptkbp:includes
|
gptkb:MERS-Co_V
gptkb:SARS-Co_V
|
|
gptkbp:is_monitored_by
|
genomic surveillance
|
|
gptkbp:is_protected_by
|
vaccination
|
|
gptkbp:is_recognized_by
|
gptkb:China
|
|
gptkbp:is_vulnerable_to
|
gptkb:vaccine
inactivated virus vaccine
viral vector vaccine
protein subunit vaccine
|
|
gptkbp:public_awareness
|
increased
|
|
gptkbp:publishes
|
cytoplasm
|
|
gptkbp:receives_funding_from
|
increased
|
|
gptkbp:research_focus
|
vaccine development
antiviral drugs
|
|
gptkbp:scientific_classification
|
high priority pathogens
|
|
gptkbp:seed_dispersal
|
single-stranded RNA
|
|
gptkbp:social_responsibility
|
serological testing
pandemics
PCR testing
global spread
|
|
gptkbp:symptoms
|
cough
fever
shortness of breath
|
|
gptkbp:transmission
|
human-to-human
animal-to-human
|
|
gptkbp:treatment
|
supportive care
monoclonal antibodies
antiviral medications
convalescent plasma
|
|
gptkbp:variant
|
gptkb:Alpha_variant
gptkb:Delta_variant
Omicron variant
Beta variant
|
|
gptkbp:bfsParent
|
gptkb:Gammacoronavirus
|
|
gptkbp:bfsLayer
|
5
|